Masonic Cancer Center, University of Minnesota
The aim of this clinical trial is to test the efficacy of a culturally aligned digital smoking cessation resource for American Indian persons who smoke, via a remotely conducted randomized controlled trial.
This is a two-arm, parallel group, randomized controlled clinical trial. Eligible participants (n=416) will be randomized to either the culturally aligned resource or the general audience version. Participants will use the assigned resource for 6 months, and partake in surveys at baseline, and 1, 3 and 6 months, during which they will be asked several questions related to use of their assigned resource, and smoking behavior. Carbon monoxide (CO) in exhaled breath will be collected at 1, 3 and 6 months using iCO™ Smokerlyzer® (https://www.icoquit.com/us/).
Inclusion Criteria: * AI race based on self-report; * ≥ 18 years of age via photo ID confirmation; * Average smoked cigarettes per day, ≥ 3 in the past 30 days; * considering or willing to make a quit attempt; * self-report having daily access to their own iPhone/Android smartphone or tablet that allows for messaging use; * able to read and speak English. Exclusion Criteria: * None
A free text message smoking cessation program that provides 24/7 encouragement, advice, and tips to those trying to quit smoking.
A free text message smoking cessation program that provides 24/7 encouragement, advice, and tips to those trying to quit smoking and has been developed for American Indian and Alaska Native persons.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.